{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:12:14Z","timestamp":1791274334517,"version":"4.1.0"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"name":"Study on intervention strategies of two-way referral behavior of doctors based on hierarchical diagnosis and treatment model","award":["RKX202302006"],"award-info":[{"award-number":["RKX202302006"]}]},{"name":"Henan Province Archives Science and Technology Research Plan","award":["2021-X-09"],"award-info":[{"award-number":["2021-X-09"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>GBM is an aggressive brain tumor with limited treatment options. Prior\nresearch has indicated FOLR1 as a pivotal gene involved in cancer pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aimed to explore the involvement of folate receptor alpha (FOLR1) in glioblastoma\n(GBM) and evaluate its potential as a therapeutic target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study investigated the expression pattern of FOLR1 in GBM, its impact on patient\nprognosis, and its role in GBM cell growth and the SRC\/ERK1\/2 signaling axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Initially, we conducted an expression analysis of FOLR1 based on public databases\nand examined its expression pattern in GBM and its impact on patient prognosis. Subsequently,\ncell experiments were carried out to evaluate the regulation of GBM cells by differential FOLR1\nexpression. We then downloaded 100 FOLR1 co-expressed genes from the Linkedomics data\nrepository and performed an enrichment analysis. Finally, the role of FOLR1 and SRC\/ERK1\/2\naxis in GBM was analyzed again by cell experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>FOLR1 was found to be substantially expressed in GBM patients and was linked to a\npoor prognosis. Cell experiments showed that overexpression of FOLR1 promoted GBM cell\ngrowth, while low expression of FOLR1 inhibited cell growth. Additionally, genes related to\nFOLR1 were enriched in the lysosome, toxoplasmosis, and other pathways. This study further\nindicated that FOLR1 facilitates the activation of the SRC\/ERK1\/2 signaling pathway in GBM\ncells, and the attenuation of these pathways can effectively impede the malignancy-promoting\neffects triggered by FOLR1 in GBM cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We revealed that FOLR1 orchestrates the malignant advancement of GBM by\nstimulating the SRC\/ERK1\/2 signaling axis, underscoring its pivotal role in the pathogenesis of\nGBM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113862073335351241226070841","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T01:15:24Z","timestamp":1737508524000},"page":"52-64","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["FOLR1 Regulates the Malignant Progression of Glioblastoma through the SRC\/ERK1\/2 Axis"],"prefix":"10.2174","volume":"29","author":[{"given":"Xueshan","family":"Jia","sequence":"first","affiliation":[{"name":"School of Public Health, Zhengzhou University, No. 100, Science Avenue, High-tech Zone, Zhengzhou, Henan 450001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, Henan Provincial People's Hospital, No.7, Weiwu Road, Zhengzhou City,450003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, the Fifth Affiliated Hospital of Zhengzhou University,Zhengzhou, Henan, 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Public Health, Zhengzhou University, No. 100, Science Avenue, High-tech Zone, Zhengzhou, Henan 450001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yi","sequence":"additional","affiliation":[{"name":"School of Public Health, Zhengzhou University, No. 100, Science Avenue, High-tech Zone, Zhengzhou, Henan 450001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Henan Provincial People's Hospital, No.7, WeiwuRoad, Zhengzhou City, 450003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Tian","sequence":"additional","affiliation":[{"name":"School of Public Health, Zhengzhou University, No. 100, Science Avenue, High-tech Zone, Zhengzhou, Henan 450001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Partridge B.R.","year":"2022","unstructured":"Partridge B.R.; Overcoming therapeutic resistance in glioblastoma using novel electroporation-based therapies. Virginia Tech  2022","journal-title":"Virginia Tech"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.ajpath.2015.02.023","volume":"185","author":"Crespo I.","year":"2015","unstructured":"Crespo I.; Vital A.L.; Gonzalez-Tablas M.; Patino M.C.; Otero A.; Lopes M.C.; de Oliveira C.; Domingues P.; Orfao A.; Tabernero M.D.; Molecular and genomic alterations in glioblastoma multiforme. Am J Pathol  2015,185(7),1820-1833","journal-title":"Am J Pathol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","volume":"129","author":"Aldape K.","year":"2015","unstructured":"Aldape K.; Zadeh G.; Mansouri S.; Reifenberger G.; von Deimling A.; Glioblastoma: Pathology, molecular mechanisms and markers. Acta Neuropathol  2015,129(6),829-848","journal-title":"Acta Neuropathol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"615400","DOI":"10.3389\/fonc.2020.615400","volume":"10","author":"Kim H.J.","year":"2021","unstructured":"Kim H.J.; Park J.W.; Lee J.H.; Genetic architectures and cell-of-origin in glioblastoma. Front Oncol  2021,10,615400","journal-title":"Front Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/neuonc\/noz123","volume":"21","author":"Ostrom Q.T.","year":"2019","unstructured":"Ostrom Q.T.; Fahmideh M.A.; Cote D.J.; Muskens I.S.; Schraw J.M.; Scheurer M.E.; Bondy M.L.; Risk factors for childhood and adult primary brain tumors. Neuro-oncol  2019,21(11),1357-1375","journal-title":"Neuro-oncol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1212\/01.CON.0000464171.50638.fa","volume":"21","author":"Butowski N.A.","year":"2015","unstructured":"Butowski N.A.; Epidemiology and diagnosis of brain tumors. Continuum (Minneap Minn)  2015,21(2),301-313","journal-title":"Continuum (Minneap Minn)"},{"key":"ref=7","first-page":"279","volume":"67","author":"Kenessey I.","year":"2023","unstructured":"Kenessey I.; Pat\u00f3cs A.; Dobozi M.; Nagy P.; Polg\u00e1r C.; The epidemiology of primary brain malignancies. Magy Onkol  2023,67(4),279-287","journal-title":"Magy Onkol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.3390\/ijms24055045","volume":"24","author":"Pagano C.","year":"2023","unstructured":"Pagano C.; Navarra G.; Coppola L.; Savarese B.; Avilia G.; Giarra A.; Pagano G.; Marano A.; Trifuoggi M.; Bifulco M.; Laezza C.; Impacts of environmental pollution on brain tumorigenesis. Int J Mol Sci  2023,24(5),5045","journal-title":"Int J Mol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-012-0983-4","volume":"111","author":"Petrecca K.","year":"2013","unstructured":"Petrecca K.; Guiot M.C.; Panet-Raymond V.; Souhami L.; Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol  2013,111(1),19-23","journal-title":"J Neurooncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1055\/s-0043-1776766","volume":"43","author":"Hardigan A.A.","year":"2023","unstructured":"Hardigan A.A.; Jackson J.D.; Patel A.P.; Surgical management and advances in the treatment of glioma. Semin Neurol  2023,43(6),810-824","journal-title":"Semin Neurol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.3390\/cimb45100524","volume":"45","author":"Yuen C.M.","year":"2023","unstructured":"Yuen C.M.; Tsai H.P.; Tseng T.T.; Tseng Y.L.; Lieu A.S.; Kwan A.L.; Chang A.Y.W.; Hyperbaric oxygen therapy adjuvant chemotherapy and radiotherapy through inhibiting stemness in glioblastoma. Curr Issues Mol Biol  2023,45(10),8309-8320","journal-title":"Curr Issues Mol Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tem.2021.12.003","volume":"33","author":"Nawaz F.Z.","year":"2022","unstructured":"Nawaz F.Z.; Kipreos E.T.; Emerging roles for folate receptor FOLR1 in signaling and cancer. Trends Endocrinol Metab  2022,33(3),159-174","journal-title":"Trends Endocrinol Metab"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.virs.2023.04.001","volume":"38","author":"Wu J.","year":"2023","unstructured":"Wu J.; Han Y.; Lyu R.; Zhang F.; Jiang N.; Tao H.; You Q.; Zhang R.; Yuan M.; Nawaz W.; Chen D.; Wu Z.; FOLR1-induced folate deficiency reduces viral replication via modulating APOBEC3 family expression. Virol Sin  2023,38(3),409-418","journal-title":"Virol Sin"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"110738","DOI":"10.1016\/j.cellsig.2023.110738","volume":"109","author":"Patrick S.","year":"2023","unstructured":"Patrick S.; Lathoria K.; Suri V.; Sen E.; Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics. Cell Signal  2023,109,110738","journal-title":"Cell Signal"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","volume":"15","author":"Gonen N.","year":"2012","unstructured":"Gonen N.; Assaraf Y.G.; Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance. Drug Resist Updat  2012,15(4),183-210","journal-title":"Drug Resist Updat"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fchem.2015.00037","volume":"3","author":"L\u00f6ser R.","year":"2015","unstructured":"L\u00f6ser R.; Pietzsch J.; Cysteine cathepsins: Their role in tumor progression and recent trends in the development of imaging probes. Front Chem  2015,3,37","journal-title":"Front Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.bcp.2011.01.023","volume":"81","author":"Garcia-Bennett A.","year":"2011","unstructured":"Garcia-Bennett A.; Nees M.; Fadeel B.; In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol  2011,81(8),976-984","journal-title":"Biochem Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/diagnostics11030465","volume":"11","author":"Atallah G.A.","year":"2021","unstructured":"Atallah G.A.; Abd Aziz N.H.; Teik C.K.; Shafiee M.N.; Kampan N.C.; New predictive biomarkers for ovarian cancer. Diagnostics (Basel)  2021,11(3),465","journal-title":"Diagnostics (Basel)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.lungcan.2017.09.002","volume":"113","author":"Kato T.","year":"2017","unstructured":"Kato T.; Jin C.S.; Ujiie H.; Lee D.; Fujino K.; Wada H.; Hu H.; Weersink R.A.; Chen J.; Kaji M.; Kaga K.; Matsui Y.; Wilson B.C.; Zheng G.; Yasufuku K.; Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer. Lung Cancer  2017,113,59-68","journal-title":"Lung Cancer"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3390\/ijms25021046","volume":"25","author":"Gonzalez T.","year":"2024","unstructured":"Gonzalez T.; Muminovic M.; Nano O.; Vulfovich M.; Folate receptor Alpha\u2014a novel approach to cancer therapy. Int J Mol Sci  2024,25(2),1046","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"121802","DOI":"10.1016\/j.lfs.2023.121802","volume":"326","author":"Varaganti P.","year":"2023","unstructured":"Varaganti P.; Buddolla V.; Lakshmi B.A.; Kim Y.J.; Recent advances in using folate receptor 1 (FOLR1) for cancer diagnosis and treatment, with an emphasis on cancers that affect women. Life Sci  2023,326,121802","journal-title":"Life Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10571-023-01448-z","volume":"44","author":"Mekler A.A.","year":"2024","unstructured":"Mekler A.A.; Schwartz D.R.; Savelieva O.E.; Genetic discrimination of grade 3 and grade 4 gliomas by artificial neural network. Cell Mol Neurobiol  2024,44(1),13","journal-title":"Cell Mol Neurobiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biom9040154","volume":"9","author":"Kucheryavykh Y.V.","year":"2019","unstructured":"Kucheryavykh Y.V.; Davila J.; Ortiz-Rivera J.; Inyushin M.; Almodovar L.; Mayol M.; Morales-Cruz M.; Cruz-Monta\u00f1ez A.; Barcelo-Bovea V.; Griebenow K.; Kucheryavykh L.Y.; Targeted delivery of nanoparticulate cytochrome C into glioma cells through the proton-coupled folate transporter. Biomolecules  2019,9(4),154","journal-title":"Biomolecules"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/CMR.0000000000000783","volume":"32","author":"Sun S.","year":"2022","unstructured":"Sun S.; Shi R.; Xu L.; Sun F.; Identification of heterogeneity and prognostic key genes associated with uveal melanoma using single-cell RNA-sequencing technology. Melanoma Res  2022,32(1),18-26","journal-title":"Melanoma Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"Liu C.J.","year":"2023","unstructured":"Liu C.J.; Hu F.F.; Xie G.Y.; Miao Y.R.; Li X.W.; Zeng Y.; Guo A.Y.; GSCA: An integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform  2023,24(1),bbac558","journal-title":"Brief Bioinform"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1177932219899051","DOI":"10.1177\/1177932219899051","volume":"14","author":"Subramanian I.","year":"2020","unstructured":"Subramanian I.; Verma S.; Kumar S.; Jere A.; Anamika K.; Multi-omics data integration, interpretation, and its application. Bioinform Biol Insights  2020,14,1177932219899051","journal-title":"Bioinform Biol Insights"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41417-021-00387-5","volume":"29","author":"Puthdee N.","year":"2022","unstructured":"Puthdee N.; Sriswasdi S.; Pisitkun T.; Ratanasirintrawoot S.; Israsena N.; Tangkijvanich P.; The LIN28B\/TGF-\u03b2\/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma. Cancer Gene Ther  2022,29(5),445-455","journal-title":"Cancer Gene Ther"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.11.008","author":"Alaseem A.","year":"2019","unstructured":"Alaseem A.; Alhazzani K.; Dondapati P.; Alobid S.; Bishayee A.; Rathinavelu A., Eds.;; Matrix Metalloproteinases: A challenging paradigm of cancer management. Seminars in cancer biology; Elsevier  2019"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.foodchem.2012.11.139","volume":"138","author":"Chen A.Y.","year":"2013","unstructured":"Chen A.Y.; Chen Y.C.; A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem  2013,138(4),2099-2107","journal-title":"Food Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41419-021-03492-3","volume":"12","author":"Yu X.","year":"2021","unstructured":"Yu X.; Jin J.; Zheng Y.; Zhu H.; Xu H.; Ma J.; Lan Q.; Zhuang Z.; Chen C.C.; Li M.; GBP5 drives malignancy of glioblastoma via the Src\/ERK1\/2\/MMP3 pathway. Cell Death Dis  2021,12(2),203","journal-title":"Cell Death Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/cancers9070087","volume":"9","author":"Cruickshanks N.","year":"2017","unstructured":"Cruickshanks N.; Zhang Y.; Yuan F.; Pahuski M.; Gibert M.; Abounader R.; Role and therapeutic targeting of the HGF\/MET pathway in glioblastoma. Cancers (Basel)  2017,9(7),87","journal-title":"Cancers (Basel)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fonc.2012.00194","volume":"2","author":"Orentas R.J.","year":"2012","unstructured":"Orentas R.J.; Yang J.J.; Wen X.; Wei J.S.; Mackall C.L.; Khan J.; Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers. Front Oncol  2012,2,194","journal-title":"Front Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1016\/j.xphs.2017.08.009","volume":"106","author":"Guo J.","year":"2017","unstructured":"Guo J.; Schlich M.; Cryan J.F.; O\u2019Driscoll C.M.; Targeted drug delivery via folate receptors for the treatment of brain cancer: Can the promise deliver? J Pharm Sci  2017,106(12),3413-3420","journal-title":"J Pharm Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00432-011-1069-y","volume":"138","author":"Orozco-Morales M.","year":"2012","unstructured":"Orozco-Morales M.; S\u00e1nchez-Garc\u00eda F.J.; Guevara-Salazar P.; Arrieta O.; Hern\u00e1ndez-Pedro N.Y.; S\u00e1nchez-Garc\u00eda A.; Perez-Madrigal R.; Rangel-L\u00f3pez E.; Pineda B.; Sotelo J.; Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin. J Cancer Res Clin Oncol  2012,138(1),23-33","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"215752","DOI":"10.1016\/j.canlet.2022.215752","volume":"541","author":"Liu Y.","year":"2022","unstructured":"Liu Y.; Wang X.; Zhu W.; Sui Z.; Wei X.; Zhang Y.; Qi J.; Xing Y.; Wang W.; TRPML1-induced autophagy inhibition triggers mitochondrial mediated apoptosis. Cancer Lett  2022,541,215752","journal-title":"Cancer Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cellsig.2007.10.002","volume":"20","author":"Dance M.","year":"2008","unstructured":"Dance M.; Montagner A.; Salles J.P.; Yart A.; Raynal P.; The molecular functions of Shp2 in the Ras\/Mitogen-activated protein kinase (ERK1\/2) pathway. Cell Signal  2008,20(3),453-459","journal-title":"Cell Signal"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.amjmed.2006.05.002","volume":"119","author":"Pasantes-Morales H.","year":"2006","unstructured":"Pasantes-Morales H.; Lezama R.A.; Ramos-Mandujano G.; Tuz K.L.; Mechanisms of cell volume regulation in hypo-osmolality. Am J Med  2006,119(7)(Suppl. 1),S4-S11","journal-title":"Am J Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/joim.12019","volume":"273","author":"Claesson-Welsh L.","year":"2013","unstructured":"Claesson-Welsh L.; Welsh M.; VEGFA and tumour angiogenesis. J Intern Med  2013,273(2),114-127","journal-title":"J Intern Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41388-020-01588-2","volume":"40","author":"Yousefi H.","year":"2021","unstructured":"Yousefi H.; Vatanmakanian M.; Mahdiannasser M.; Mashouri L.; Alahari N.V.; Monjezi M.R.; Ilbeigi S.; Alahari S.K.; Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance. Oncogene  2021,40(6),1043-1063","journal-title":"Oncogene"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1042\/BST20220271","volume":"50","author":"Lucas R.M.","year":"2022","unstructured":"Lucas R.M.; Luo L.; Stow J.L.; ERK1\/2 in immune signalling. Biochem Soc Trans  2022,50(5),1341-1352","journal-title":"Biochem Soc Trans"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"119499","DOI":"10.1016\/j.lfs.2021.119499","volume":"278","author":"Asl E.R.","year":"2021","unstructured":"Asl E.R.; Amini M.; Najafi S.; Mansoori B.; Mokhtarzadeh A.; Mohammadi A.; Lotfinejad P.; Bagheri M.; Shirjang S.; Lotfi Z.; Rasmi Y.; Baradaran B.; Interplay between MAPK\/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression. Life Sci  2021,278,119499","journal-title":"Life Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/15353702221139183","volume":"248","author":"Lee S.","year":"2023","unstructured":"Lee S.; Park S.; Ryu J.S.; Kang J.; Kim I.; Son S.; Lee B.S.; Kim C.H.; Kim Y.S.; c-Src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial\u2013mesenchymal transition. Exp Biol Med (Maywood)  2023,248(6),492-500","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"F660","DOI":"10.1152\/ajprenal.00480.2018","volume":"316","author":"Tao M.","year":"2019","unstructured":"Tao M.; Shi Y.; Tang L.; Wang Y.; Fang L.; Jiang W.; Lin T.; Qiu A.; Zhuang S.; Liu N.; Blockade of ERK1\/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy. Am J Physiol Renal Physiol  2019,316(4),F660-F673","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.3390\/ijms23136894","volume":"23","author":"Chuli\u00e1-Peris L.","year":"2022","unstructured":"Chuli\u00e1-Peris L.; Carreres-Rey C.; Gabasa M.; Alcaraz J.; Carretero J.; Pereda J.; Matrix metalloproteinases and their inhibitors in pulmonary fibrosis: EMMPRIN\/CD147 comes into play. Int J Mol Sci  2022,23(13),6894","journal-title":"Int J Mol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"Cabral-Pacheco G.A.","year":"2020","unstructured":"Cabral-Pacheco G.A.; Garza-Veloz I.; Castruita-De la Rosa C.; Ramirez-Acu\u00f1a J.M.; Perez-Romero B.A.; Guerrero-Rodriguez J.F.; Martinez-Avila N.; Martinez-Fierro M.L.; The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci  2020,21(24),9739","journal-title":"Int J Mol Sci"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113862073335351241226070841","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/238646\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113862073335351241226070841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:45:21Z","timestamp":1771479921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/238646\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113862073335351241226070841","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}